MELYNDA BROWN: Open Payments
NPI 1851678106 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,275 in 44 payments from 11 companies in 2025. Trend: 2023 $894 · 2024 $1,090 · 2025 $2,275
Food & beverage: $1,803Travel & lodging: $472
| Company | Payments | Amount |
|---|---|---|
| Saluda Medical Americas, Inc. | 9 | $1,464 |
| Boston Scientific Corporation | 13 | $278 |
| Collegium Pharmaceutical, Inc. | 10 | $241 |
| TerSera Therapeutics LLC | 4 | $114 |
| ABBVIE INC. | 2 | $36 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $31 |
| Merz Pharmaceuticals, LLC | 1 | $28 |
| Nalu Medical, Inc. | 1 | $27 |
| Medtronic, Inc. | 1 | $22 |
| REVANCE THERAPEUTICS, INC. | 1 | $18 |
Products named: Evoke, Belbuca, Intracept, Prialt, XTAMPZA, General - Pain Management, Intracept RF Probe, Xeomin.
Industry payments across FL — which companies pay providers there.
